SCHEMBL6224403

SCHEMBL6224403

CCC(C)(CC)C(NC(=O)C(NC(=O)OCc1ccccc1)C1CCCCC1)C(=O)N1C(C(=O)OC(C)(C)C)CC2CCCCC21

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.44
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
ACE P12821 6/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
SYK P43405 1/20 0.39
CASP1 P29466 2/20 0.39
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
FKBP1A P62942 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3051904 0.94 CTSL (0.46) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL13245760 0.94 CTSL (0.46) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL3051377 0.85 CTSL (0.47) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL10077634 0.85 CTSL (0.47) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL9732240 0.83 ACE (0.51) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL12237103 0.79 CTSL (0.47) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL9256682 0.79 CTSL (0.54) CTSLACEMEN1KMT2AUSP2
SCHEMBL29771972 0.79 CTSL (0.54) CTSLADORA3ADORA2AADORA2BADORA1
SCHEMBL14350234 0.78 HTRA1 (0.39) CTSLACEMEN1KMT2AUSP2
SCHEMBL10076845 0.78 HTRA1 (0.39) CTSLACEMEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1497282-A2 INHIBITORS OF SERINE PROTEASE, PARTICULARLY HEPATITIS C VIRUS NS3-NS4 PROTEASE Vertex Pharmaceuticals Incorporated (US) 2005-01-19 EP disclosed
WO-2003087092-A2 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 - NS4 PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-10-23 WO disclosed